Attack of single-payer could be winning strategy for California GOP

Five months before the 2018 midterm elections, California Republicans see their opponents’ embrace of exploring single-payer healthcare as an opportunity.

“My opponent wants socialized medicine and government-run health care,” Rep. Mimi Walters, R-California, told The Hill. “The district does not support it.”

Democratic leadership has toyed with “Medicare for all” in recent months, but Republicans believe moderates in key districts in California—including seven GOP-held seats that are top targets for Democratcs—will reject such a leftward lurch.

“It does really well right now, but will that change with millions of dollars of spending in a concerted effort by Republicans to make people feel like Medicare for all means trillions of dollars in tax increases?” one Democratic strategist told The Hill.

Read more at the link below:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.